Relationships of serum Xenin-25 and activin A expression levels with pregnancy outcome in patients with gestational diabetes mellitus
- VernacularTitle:妊娠期糖尿病患者血清赛宁-25、激活素A表达水平与妊娠结局的关系
- Author:
Yongjuan QUAN
1
;
Haijuan DENG
;
Fen LI
Author Information
- Keywords: gestational diabetes mellitus; adverse pregnancy outcomes; blood sugar control; serum Xenin-25; activin A
- From: Journal of Clinical Medicine in Practice 2025;29(4):55-59
- CountryChina
- Language:Chinese
- Abstract: Objective To investigate the relationships of serum levels of Xenin-25 and activin A with pregnancy outcomes in patients with gestational diabetes mellitus(GDM).Methods A total of 269 pregnant women with GDM admitted to our hospital between December 2020 and February 2023 were enrolled.Serum levels of Xenin-25 and activin A were measured,and pregnancy outcomes were recorded.Based on pregnancy outcomes,patients were divided into poor pregnancy outcome group(91 cases)and good pregnancy outcome group(178 cases).The influencing factors of adverse preg-nancy outcomes of GDM patients and the predictive value of Xenin-25 and activin A for GDM preg-nancy outcomes were analyzed.Results The poor pregnancy outcome group had higher age,pre-pregnancy body mass index(BMI),proportion of adverse obstetric history,as well as levels of fasting plasma glucose(FPG),glycated hemoglobin(HbA1c),and activin A compared to the good preg-nancy outcome group,and serum level of Xenin-25 was lower in the poor pregnancy outcome group(P＜0.05).High HbA1c and high activin A levels were identified as risk factors for pregnancy out-comes in GDM patients,while high Xenin-25 was a protective factor for pregnancy outcomes(P＜0.05).The areas under the curve(AUCs)for predicting adverse pregnancy outcomes in GDM pa-tients using Xenin-25 and activin A were 0.895 and 0.865,respectively,while the AUC for com-bined prediction was 0.981,which was higher than that of Xenin-25 or activin A alone(P＜0.05).Conclusion Xenin-25 and activin A in GDM patients are associated with adverse pregnancy outcomes and can serve as biomarkers for predicting pregnancy outcomes.
